Andrew L. Coveler, MD
Associate Professor, University of Washington, Fred Hutchinson Cancer Center; and Interim Director of Clinical Trials, Cancer Vaccine Institute
Andrew Coveler, MD, is an associate professor in the Division of Medical Oncology at the University of Washington School of Medicine and in the Clinical Research Division at Fred Hutchinson Cancer Research Center in Seattle, Washington, USA. He is the Interim Director of the Cancer Vaccine Institute.
Dr. Coveler received his medical degree from Northwestern University Feinberg School of Medicine in Chicago, Illinois. He completed his internship at Baylor College of Medicine in Houston, Texas, his internal medicine residency at the University of Washington, and a hematology-oncology fellowship at the Fred Hutchinson Cancer Center.
He specializes in the treatment of gastrointestinal cancers. Dr. Coveler’s research encompasses phase I, II and III in GI malignancies, novel agents, and immunotherapy trials. He did one imaging study in medical school and otherwise has worked in clinical trials since 2005.
Dr. Coveler is author or co-author of 3 book chapters, 35 peer reviewed journal articles and 54 abstracts. He has published articles in NEJMm JAMA Oncology, Oncotarget, Current Oncology Reports, Investigational New Drugs and ASCO Education Book, among others.